Institution
Maimonides Medical Center
Healthcare•New York, New York, United States•
About: Maimonides Medical Center is a healthcare organization based out in New York, New York, United States. It is known for research contribution in the topics: Population & Medicine. The organization has 2895 authors who have published 3487 publications receiving 103161 citations.
Papers published on a yearly basis
Papers
More filters
Theo Vos1, Amanuel Alemu Abajobir, Kalkidan Hassen Abate2, Cristiana Abbafati3 +775 more•Institutions (305)
TL;DR: The Global Burden of Diseases, Injuries, and Risk Factors Study 2016 (GBD 2016) provides a comprehensive assessment of prevalence, incidence, and years lived with disability (YLDs) for 328 causes in 195 countries and territories from 1990 to 2016.
10,401 citations
Gregory A. Roth1, Gregory A. Roth2, Degu Abate3, Kalkidan Hassen Abate4 +1025 more•Institutions (333)
TL;DR: Non-communicable diseases comprised the greatest fraction of deaths, contributing to 73·4% (95% uncertainty interval [UI] 72·5–74·1) of total deaths in 2017, while communicable, maternal, neonatal, and nutritional causes accounted for 18·6% (17·9–19·6), and injuries 8·0% (7·7–8·2).
5,211 citations
Jeffrey D. Stanaway1, Ashkan Afshin1, Emmanuela Gakidou1, Stephen S Lim1 +1050 more•Institutions (346)
TL;DR: This study estimated levels and trends in exposure, attributable deaths, and attributable disability-adjusted life-years (DALYs) by age group, sex, year, and location for 84 behavioural, environmental and occupational, and metabolic risks or groups of risks from 1990 to 2017 and explored the relationship between development and risk exposure.
2,910 citations
Maimonides Medical Center1, Radiation Therapy Oncology Group2, European Organisation for Research and Treatment of Cancer3, Institut Gustave Roussy4, Johns Hopkins University School of Medicine5, University of Lausanne6, Wayne State University7, Gdańsk Medical University8, University of Texas MD Anderson Cancer Center9
TL;DR: Level I evidence was established for the postoperative adjuvant treatment of patients with selected high‐risk locally advanced head and neck cancers, with the publication of the results of two trials conducted in Europe and the United States.
Abstract: Background. In 2004, level I evidence was estab- lished for the postoperative adjuvant treatment of patients with selected high-risk locally advanced head and neck cancers, with the publication of the results of two trials conducted in Europe
1,372 citations
TL;DR: It is demonstrated that PET scanning is more accurate than CT scanning, but tissue biopsy is still required to confirm PET scan findings, and evidence suggests that more complete staging improves patient outcomes.
1,167 citations
Authors
Showing all 2919 results
| Name | H-index | Papers | Citations |
|---|---|---|---|
| Valentin Fuster | 179 | 1462 | 185164 |
| Stuart A. Lipton | 134 | 488 | 71297 |
| Michael L. Blute | 112 | 527 | 45296 |
| Carl J. Lavie | 106 | 1135 | 49318 |
| Bradford B. Lowell | 101 | 213 | 53866 |
| Patrick M. Schlievert | 90 | 444 | 32037 |
| Juan J. Badimon | 88 | 442 | 36484 |
| Blas Frangione | 82 | 322 | 26980 |
| Frank J. Schwab | 81 | 749 | 27961 |
| Barry R. Davis | 78 | 342 | 47899 |
| Saulo Klahr | 76 | 331 | 34034 |
| Jorge Ghiso | 73 | 221 | 21051 |
| Steven R. Levine | 72 | 305 | 27909 |
| Debabrata Mukherjee | 70 | 514 | 38080 |
| Ravi Bhatia | 67 | 312 | 14533 |